Heartseed Inc., Breakthrough cell therapy for severe heart failure.
As an innovative new treatment option for heart failure, a unique cardiac remuscularization therapy has […]
How to assess start-up companies
Relevant soft factors to assess startup companies Investing in early-stage companies is a risky business. […]
Site Selection for Life Sciences Companies in Asia – New Report in Collaboration with KPMG
Zurich / Singapore, July 2020 – In response to the growing need of life sciences […]
Do Biotech Investors stick to their Home Market?
It is no surprise that most biotech investors are based in the US. But, do […]
J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate
14 January 2019. Last week saw the annual J.P. Morgan Healthcare Conference held in San […]
The Mandarin translation of Site Selection Report for Life Sciences Companies in Europe 2018
Site Selection Report for Life Sciences Companies in Europe 2018 is now available in Mandarin […]
Site Selection Report for Life Sciences Companies in Europe 2018
The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in […]
Life Sciences clusters in Europe Report 2016
Venture Valuation together with KPMG and EuropaBio has published its most recent report at BIO […]
How strong is the London-Cambridge cluster within the UK?
See our exclusive 2015 analysis we did for the Genesis conference (organized by our partner […]
Life Sciences Clusters in Europe
What makes a European Life Science site attractive to foreign investors? Together with KPMG Switzerland […]